✦ LIBER ✦

47 POSTER A phase II study of Sorafenib (BAY 43-9006) in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN) and nasopharyngeal cancer (NPC): final results

✍ Scribed by C. Elser; L. Siu; E. Winquist; M. Agulnik; G. Pond; S. Chin; P. Francis; R. Cheiken; O. Petrenciuc; E. Chen

Book ID: 118623676
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 60 KB
Volume: 4
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(06)70053-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1029 POSTER A phase II study of sorafeni

1029 POSTER A phase II study of sorafenib (BAY 43–9006) in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal cancer (NPC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB

A randomized phase II study of docetaxel

A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)

✍ Limaye, Sewanti; Riley, Sarah; Zhao, Sihai; O’Neill, Anne; Posner, Marshall; Adk 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 375 KB

843 - Phase II study of vinorelbine (NVB

843 - Phase II study of vinorelbine (NVB) in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck (SCCHN)

✍ M. Degardin; Ph. Bastit; F. Rolland; J.P. Armand; B. Chevallier; M. Van Glabbeke 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 217 KB

995 ORAL A phase II trial of BAY 43–9006

995 ORAL A phase II trial of BAY 43–9006 in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC). a Southwest Oncology Group (SWOG) trial

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Phase II study of the antiangiogenesis a

Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck

✍ Jennifer E. Tseng; Bonnie S. Glisson; Fadlo R. Khuri; Dong M. Shin; Jeffrey N. M 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 3 views

1023 POSTER Phase II study of capecitabi

1023 POSTER Phase II study of capecitabine (X) plus reirradiation in patients (pts) with recurrent squamous cell carcinoma of the head and neck (SCCHN)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 137 KB